Sign in close

Forgot Password?
No account yet? Create an Account
  • NEWS
  • MICRO-IMMUNOTHERAPY
    • What is micro-immunotherapy?
    • The immune system
    • Find a healthcare professional
    • Clinics and health centers
    • Therapeutic areas
    • Scientific papers
    • Testimonials
    • Brochures for patients & the general public
  • ACTIVITIES
  • SERVICES
    • HelpMi platform
    • Activities in other countries
    • Our network
  • ICoMI 2022
  • PROFESSIONAL AREA
    • WikiMi – Documents & training materials
    • Calendar
    • HelpMi platform
    • Monitoring the immune system
    • Logout
  • CONTACT
    • About us
    • Contact us
    • Share your experience

Shopping cart

close
DE ES FR
Micro-immunotherapy
Close

Professional Area

DE ES FR
Cart (o) 0 / 0,00 €
  • NEWS
  • MICRO-IMMUNOTHERAPY
    • What is micro-immunotherapy?
    • The immune system
    • Find a healthcare professional
    • Clinics and health centers
    • Therapeutic areas
    • Scientific papers
    • Testimonials
    • Brochures for patients & the general public
  • ACTIVITIES
  • SERVICES
    • HelpMi platform
    • Activities in other countries
    • Our network
  • ICoMI 2022
  • PROFESSIONAL AREA
    • WikiMi – Documents & training materials
    • Calendar
    • HelpMi platform
    • Monitoring the immune system
    • Logout
  • CONTACT
    • About us
    • Contact us
    • Share your experience

In the Spotlight

Read More
24 Jan
ICoMI, News

ICoMI’s abstract submission deadline extended

  • 24 January, 2022
  • Posted by
Upon several requests, the abstract submission deadline for ICoMI2022 has been...

Read more

  • Facebook
  • Twitter
  • Email
  • LinkedIn
  • WhatsApp
  • WhatsApp
  • Telegram
Read More
18 Jan
Micro-immunotherapy International, News, Training courses

Webinar in Portuguese by Dr Alexandra Vasconcelos next January 31

  • 18 January, 2022
  • Posted by
Dr Alexandra Vasconcelos, micro-immunotherapist and founder of Clínicas Viver, is giving...

Read more

  • Facebook
  • Twitter
  • Email
  • LinkedIn
  • WhatsApp
  • WhatsApp
  • Telegram
Read More
10 Jan
Micro-immunotherapy International, News

Check out the latest study on the effects of micro-immunotherapy in our section Scientific Papers

  • 10 January, 2022
  • Posted by
This year 2022 starts with a piece of good news and...

Read more

  • Facebook
  • Twitter
  • Email
  • LinkedIn
  • WhatsApp
  • WhatsApp
  • Telegram
Read More
27 Dec
Micro-immunotherapy International, News

Micro-immunotherapy supports the project Waisenkinder Tanzania helping orphans and street children

  • 21 December, 2021
  • Posted by
Waisenkinder Tanzania is an organization helping traumatized children in Eastern Africa,...

Read more

  • Facebook
  • Twitter
  • Email
  • LinkedIn
  • WhatsApp
  • WhatsApp
  • Telegram
Merry Christmas
Read More
20 Dec
Micro-immunotherapy International, News

Whatever the circumstances, bring a smile to Christmas!

  • 20 December, 2021
  • Posted by
Above all, Christmas is a time for celebrating life. It is...

Read more

  • Facebook
  • Twitter
  • Email
  • LinkedIn
  • WhatsApp
  • WhatsApp
  • Telegram
Beautiful young woman lying down on the field in green grass, blowing dandelions and smiling
Read More
13 Dec
News

The allergy season is close at hand: use micro-immunotherapy preventively

  • 13 December, 2021
  • Posted by
Micro-immunotherapy has proven to be of invaluable help in supporting therapeutic...

Read more

  • Facebook
  • Twitter
  • Email
  • LinkedIn
  • WhatsApp
  • WhatsApp
  • Telegram
Read More
09 Dec
Micro-immunotherapy International, News

Clínicas Viver opens in Portugal

  • 9 December, 2021
  • Posted by
Clínicas Viver has opened its doors in Lisbon and Vila Nova...

Read more

  • Facebook
  • Twitter
  • Email
  • LinkedIn
  • WhatsApp
  • WhatsApp
  • Telegram
Read More
01 Dec
ICoMI, News

Committees are getting ready for ICoMI2022!

  • 2 December, 2021
  • Posted by
Dr Pascal Mensah, ICoMI's Scientific and Medical Director, and Prof. Stephan...

Read more

  • Facebook
  • Twitter
  • Email
  • LinkedIn
  • WhatsApp
  • WhatsApp
  • Telegram
Read More
29 Nov
News

Chronic Fatigue Syndrome (CFS) laid bare in a new documentary

  • 29 November, 2021
  • Posted by
Chronic Fatigue Syndrome is a pathology affecting many. The disease is...

Read more

  • Facebook
  • Twitter
  • Email
  • LinkedIn
  • WhatsApp
  • WhatsApp
  • Telegram
Read More
22 Nov
News, Training courses

Micro-immunotherapy trainings in the language you choose

  • 22 November, 2021
  • Posted by
Language shouldn't stop you from training yourself in micro-immunotherapy. This is...

Read more

  • Facebook
  • Twitter
  • Email
  • LinkedIn
  • WhatsApp
  • WhatsApp
  • Telegram
Read More
15 Nov
News

Dr Stanton’s Health Podcast Series available on Spotify

  • 15 November, 2021
  • Posted by
Why is micro-immunotherapy a treatment so fit for today's health challenges?...

Read more

  • Facebook
  • Twitter
  • Email
  • LinkedIn
  • WhatsApp
  • WhatsApp
  • Telegram
Read More
08 Nov
News

DetectEBV: the Epstein-Barr collaborative group is up and running

  • 8 November, 2021
  • Posted by
Browse the Linkedin page of the new EBV participatory movement! It...

Read more

  • Facebook
  • Twitter
  • Email
  • LinkedIn
  • WhatsApp
  • WhatsApp
  • Telegram
123
Close

LATEST POSTS
  • Micro-immunotherapy in Slovak

    Micro-immunotherapy in Slovak

    26 May, 2022
  • ICoMI2022: discover the final Programme!

    ICoMI2022: discover the final Programme!

    9 May, 2022
  • Micro-immunotherapy and migraine

    Micro-immunotherapy and migraine

    25 April, 2022
  • Bone remodeling and micro-immunotherapy

    Bone remodeling and micro-immunotherapy

    12 April, 2022
  • The ICoMI2022 Provisional Programme is out now!

    The ICoMI2022 Provisional Programme is out now!

    4 April, 2022

Micro-Immunotherapy

Links of interest
  • Terms of use
  • Cookies policy
  • Data protection policy
Contact Information

If you would like to have more information about micro-immunotherapy and our training activities, do not hesitate to contact us by email or by filling our online contact form.

E-mail: micro-immunotherapy@micro-immunotherapy.com
FB linkedIn Insta FB

© 2022 Micro-immunotherapy. All rights reserved

This website uses cookies to analyse our website performance and enhance your browsing experience. To consent to our use of cookies please click “accept cookies”, to object please click “cookie settings” and use our cookies manager. To find out more and change your cookie settings please see our cookies policy.

AcceptCookie settings
Privacy & Cookies Policy

Privacy Overview

This website uses necessary technical cookies that are essential for the correct functioning of our website. In order to analyse statistics on the traffic and volume of visits, this website uses as well first-party and third-party audience measurement cookies. First-party cookies from Google Analytics are used to gather aggregate information such as the number of people visiting our website or which pages are the most visited. This helps us gather feedback so that we can improve our Micro-immunotherapy web site and better serve our users. Third-party cookies from platforms such as LinkedIn and Facebook are used to measure, optimize and build audiences for social media campaigns and analyse social media interaction.


When you first visit our website, you may choose whether to accept or refuse these cookies. Necessary cookies will still remain activated.


Click here to see the complete cookies policy
Necessary
Always Enabled
These cookies include those that are absolutely essential for the website to function properly, ensuring basic functionalities and security features of the website, as well as first-party audience measurement cookies that help us improve our website and services. These cookies do not store any personal information.
Non-necessary
Third-party audience measurement cookies refer to those which are not essential for the proper functioning of the website and are specifically used to analyse information on social media views and interaction and gather information on your content preferences.
SAVE & ACCEPT
Scroll To Top Sidebar